Effects of Common Polymorphisms in the MTHFR and ACE Genes on Diabetic Peripheral Neuropathy Progression: a Meta-Analysis

Molecular Neurobiology

Volumn 54, Issue 4, 2017, Pages 2435-2444

  Wu, Shuai ^a   Han, Yan ^a   Hu, Qiang ^b   Zhang, Xiaojie ^c   Cui, Guangcheng ^c   Li, Zezhi ^d   Guan, Yangtai ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANDONG MENTAL HEALTH CENTER   (China)

^c QIQIHAR MEDICAL UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

ACE; Diabetic peripheral neuropathy; Genetic polymorphism; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DIPEPTIDYL CARBOXYPEPTIDASE; ACE PROTEIN, HUMAN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

ACE GENE; ALLELE; ARTICLE; CORRELATIONAL STUDY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; GENE; GENE MUTATION; GENOTYPE; HUMAN; JAPANESE (CITIZEN); MTHFR GENE; PAKISTANI; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); TURKEY (REPUBLIC); ADOLESCENT; AGED; FEMALE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETICS; MALE; META ANALYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOLOGY; PUBLISHING; REGRESSION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; AGED; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; FEMALE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; REGRESSION ANALYSIS;

EID: 84960439560     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-016-9823-4     Document Type: Article

References (37)

1. Tesfaye S, Boulton AJ, Dyck PJ et al (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33:2285–2293
2. Varkonyi T, Kempler P (2008) Diabetic neuropathy: new strategies for treatment. Diabetes Obes Metab 10:99–108
3. Yan JE, Yuan W, Lou X et al (2012) Streptozotocin-induced diabetic hyperalgesia in rats is associated with upregulation of Toll-like receptor 4 expression. Neurosci Lett 526:54–58
4. Wong MC, Chung JW, Wong TK (2007) Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ 335:87
5. Monastiriotis C, Papanas N, Veletza S et al (2012) APOE gene polymorphisms and diabetic peripheral neuropathy. Arch Med Sci 8:583–588
6. Inanir A, Basol N, Karakus N et al (2013) The importance of association between angiotensin-converting enzyme (ACE) Gene I/D polymorphism and diabetic peripheral neuropathy. Gene 530:253–256
7. Tesfaye S, Selvarajah D (2012) Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev 28(Suppl 1):8–14
8. Yigit S, Karakus N, Inanir A (2013) Association of MTHFR gene C677T mutation with diabetic peripheral neuropathy and diabetic retinopathy. Mol Vis 19:1626–1630
9. Papanas N, Vinik AI, Ziegler D (2011) Neuropathy in prediabetes: does the clock start ticking early? Nat Rev Endocrinol 7:682–690
10. Miranda-Massari JR, Gonzalez MJ, Jimenez FJ et al (2011) Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control. Curr Clin Pharmacol 6:260–273
11. Jurado J, Ybarra J, Romeo JH et al (2012) Angiotensin-converting enzyme gene single polymorphism as a genetic biomarker of diabetic peripheral neuropathy: longitudinal prospective study. J Diabetes Complicat 26:77–82
12. Purnamasari D, Widjojo BD, Antono D et al (2012) ACE gene polymorphism and atherosclerotic lesion of carotid artery among offsprings of type 2 diabetes mellitus. Acta Med Indones 44:128–134
13. Mansoor Q, Javaid A, Bilal N et al (2012) Angiotensin-converting enzyme (ACE) gene II genotype protects against the development of diabetic peripheral neuropathy in type 2 diabetes mellitus. J Diabetes 4:257–261
14. Doria A, Warram JH, Krolewski AS (1994) Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 43:690–695
15. Osawa N, Koya D, Araki S et al (2007) Combinational effect of genes for the renin-angiotensin system in conferring susceptibility to diabetic nephropathy. J Hum Genet 52:143–151
16. Zhou D, Ruiter R, Zhang J et al (2012) Angiotensin-converting enzyme I/D polymorphism is not associated with type 2 diabetes in a Chinese population. J Renin Angiotensin Aldosterone Syst 13:372–378
17. Qin X, Li J, Cui Y et al (2012) Effect of folic acid intervention on the change of serum folate level in hypertensive Chinese adults: do methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms affect therapeutic responses? Pharmacogenet Genomics 22:421–428
18. Ukinc K, Ersoz HO, Karahan C et al (2009) Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy. Endocrine 36:255–261
19. Goyette P, Sumner JS, Milos R et al (1994) Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet 7:551
20. Li JB, Cheng YZ, Shi M et al (2011) The relationship between plasma homocysteine levels and diabetic peripheral neuropathy. Chin J Internal Med 50:14–17
21. Jianbo L, Yuche C, Ming S et al (2011) Association of homocysteine with peripheral neuropathy in Chinese patients with type 2 diabetes. Diabetes Res Clin Pract 93:38–42
22. Ambrosch A, Dierkes J, Lobmann R et al (2001) Relation between homocysteinaemia and diabetic neuropathy in patients with type 2 diabetes mellitus. Diabet Med 18:185–192
23. da Costa BR, Cevallos M, Altman DG et al (2011) Uses and misuses of the STROBE statement: bibliographic study. BMJ Open 1:e000048
24. Jackson D, White IR, Riley RD (2012) Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med 31:3805–3820
25. Peters JL, Sutton AJ, Jones DR et al (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295:676–680
26. Zintzaras E, Ioannidis JP (2005) HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 21:3672–3673
27. Sun L, Chen L, Ren JM et al (2004) Relationship of plasma homocysteine and gene polymorphism of homocysteine metabolism related enzyme with diabetic peripheral neuropathy. Chin J Endocrinol Metab 20:536–537
28. Hibberd ML, Millward BA, Demaine AG (1997) The angiotensin I-converting enzyme (ACE) locus is strongly associated with age and duration of diabetes in patients with type I diabetes. J Diabetes Complicat 11:2–8
29. Ito H, Tsukui S, Kanda T et al (2002) Angiotensin-converting enzyme insertion/deletion polymorphism and polyneuropathy in type 2 diabetes without macroalbuminuria. J Int Med Res 30:476–482
30. Toffoli G, Russo A, Innocenti F et al (2003) Effect of methylenetetrahydrofolate reductase 677C--> T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients. Int J Cancer 103:294–299
31. Xuan C, Bai XY, Gao G et al (2011) Association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) C677T and risk of myocardial infarction: a meta-analysis for 8,140 cases and 10,522 controls. Arch Med Res 42:677–685
32. Ilhan N, Kucuksu M, Kaman D et al (2008) The 677 C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels. Arch Med Res 39:125–130
33. Dhar S, Ray S, Dutta A et al (2012) Polymorphism of ACE gene as the genetic predisposition of coronary artery disease in Eastern India. Indian Heart J 64:576–581
34. Mollnau H, Wendt M, Szocs K et al (2002) Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90:E58–E65
35. Cotter MA, Cameron NE (2003) Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. Life Sci 73:1813–1824
36. Pasha MA, Khan AP, Kumar R et al (2002) Variations in angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian populations of different ethnic origins. J Biosci 27:67–70
37. Ay C, Bencur P, Vormittag R et al (2007) The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study. Thromb Haemost 98:777–782